Enanta Pharmaceuticals Inc
NASDAQ:ENTA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Enanta Pharmaceuticals Inc
NASDAQ:ENTA
|
US |
|
G
|
Greenlit Ventures Inc
OTC:GLVT
|
US |
|
I
|
Ipsen SA
OTC:IPSEF
|
FR |
|
C
|
CITIC Ltd
XMUN:CPF
|
CN |
|
C
|
China Gas Holdings Ltd
OTC:CGHLY
|
HK |
Intrinsic Value
Is ENTA undervalued or overvalued?
See the intrinsic value estimate for Enanta Pharmaceuticals Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
ENTA looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with ENTA’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Enanta Pharmaceuticals Does
Enanta Pharmaceuticals is a drug discovery company that focuses on small-molecule medicines for viral infections and immune-related diseases. It does not mainly sell drugs under its own brand; instead, it researches new compounds, runs early clinical development, and often hands successful programs to larger pharmaceutical companies for late-stage testing and commercialization.
- Headquarters
- United States of America US
- Employees
- 120
- IPO date
- Mar 21, 2013
Revenue & Expenses Breakdown
Enanta Pharmaceuticals Inc
Earnings Waterfall
Enanta Pharmaceuticals Inc
The intrinsic value for Enanta Pharmaceuticals Inc (ENTA) under the Base Case is hidden USD.
Compared with the current market price of 11.64 USD, the stock appears hidden.